Opill, the first over-the-counter birth control pill, is set to hit drugstores, grocery stores and online shelves in the first quarter of 2024. But the real challenge lies ahead: Will it be affordable and truly accessible to all?

Opill is a progestin-only oral contraceptive pill, boasting a success rate as high as 98 percent in preventing pregnancies.  The U.S. Food and Drug Administration hailed the approval of Opill as a breakthrough that could “reduce barriers to access” for those seeking contraception. 

However, the promise of accessibility hinges on the crucial factor of affordability.